BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alipour M. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J Gastrointest Cancer. 2021;52:23-30. [PMID: 32926335 DOI: 10.1007/s12029-020-00518-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Collatuzzo G, La Vecchia C, Parazzini F, Alicandro G, Turati F, Di Maso M, Malvezzi M, Pelucchi C, Negri E, Boffetta P. Cancers attributable to infectious agents in Italy. Eur J Cancer 2023;183:69-78. [PMID: 36801622 DOI: 10.1016/j.ejca.2023.01.010] [Reference Citation Analysis]
2 Chen R, Li Y, Chen X, Chen J, Song J, Yang X, Ye L, Wu Z, Xie P, Zhong Q, Yang R, Wu J. dupA+H. pylori reduces diversity of gastric microbiome and increases risk of erosive gastritis. Front Cell Infect Microbiol 2023;13. [DOI: 10.3389/fcimb.2023.1103909] [Reference Citation Analysis]
3 Qiu P, Li X, Gong M, Wen P, Wen J, Xu L, Wang G. SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/AKT/mTOR Pathway. Canadian Journal of Gastroenterology and Hepatology 2023;2023:1-13. [DOI: 10.1155/2023/2021515] [Reference Citation Analysis]
4 Ju F, Peng J, Zhang Y, Zhou L, Yao S, Wang D, Zhu Y, Liu J, Li L, Bao J, Tang S. Helicobacter pylori infection accelerates gastric cancer development by acting on the miR-146a-5p/FHL1 axis.. [DOI: 10.21203/rs.3.rs-2676039/v1] [Reference Citation Analysis]
5 Suenaga S, Takano Y, Saito T. Unraveling Binding Mechanism and Stability of Urease Inhibitors: A QM/MM MD Study. Molecules 2023;28:2697. [DOI: 10.3390/molecules28062697] [Reference Citation Analysis]
6 Liu X, Ren Y, Wang F, Bu Y, Peng L, Liang J, Kang X, Zhang H. Development and validation of prognostic nomogram for patients with metastatic gastric adenocarcinoma based on the SEER database. Medicine (Baltimore) 2023;102:e33019. [PMID: 36862921 DOI: 10.1097/MD.0000000000033019] [Reference Citation Analysis]
7 Attard TM, Omar U, Glynn EF, Stoecklein N, St Peter SD, Thomson MA. Gastric cancer in the pediatric population, a multicenter cross-sectional analysis of presentation and coexisting comorbidities. J Cancer Res Clin Oncol 2023;149:1261-72. [PMID: 35435488 DOI: 10.1007/s00432-022-03972-9] [Reference Citation Analysis]
8 Xia C, Su J, Liu C, Mai Z, Yin S, Yang C, Fu L. Human microbiomes in cancer development and therapy. MedComm (2020) 2023;4:e221. [PMID: 36860568 DOI: 10.1002/mco2.221] [Reference Citation Analysis]
9 Jardim SR, de Souza LMP, de Souza HSP. The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress? Int J Environ Res Public Health 2023;20. [PMID: 36834334 DOI: 10.3390/ijerph20043640] [Reference Citation Analysis]
10 Chen M, Cui Y, Liu C, Tong X, Wang M, Wu C, Liu Y, Zhao Y, Chen X. Characteristics of the microbiome in lung adenocarcinoma tissue from patients in Kunming city of southwestern China. Environ Sci Pollut Res Int 2023. [PMID: 36787077 DOI: 10.1007/s11356-023-25528-1] [Reference Citation Analysis]
11 Javed A, Yarmohammadi M, Korkmaz KS, Rubio-Tomás T. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. Int J Mol Sci 2023;24. [PMID: 36769170 DOI: 10.3390/ijms24032848] [Reference Citation Analysis]
12 Zhu Y, Zhu F, Ba H, Chen J, Bian X. Helicobacter pylori infection and PD-L1 expression in gastric cancer: A meta-analysis. Eur J Clin Invest 2023;53:e13880. [PMID: 36164962 DOI: 10.1111/eci.13880] [Reference Citation Analysis]
13 Wang Y, Zheng L. Protocatechuic acid, the main effective monomer in Wuqi Powder, can inhibit gastric ulcers induced by acetic acid and Helicobacter pylori. Am J Transl Res 2023;15:151-64. [PMID: 36777827] [Reference Citation Analysis]
14 Guo Y, Cao XS, Zhou MG, Yu B. Gastric microbiota in gastric cancer: Different roles of Helicobacter pylori and other microbes. Front Cell Infect Microbiol 2022;12:1105811. [PMID: 36704105 DOI: 10.3389/fcimb.2022.1105811] [Reference Citation Analysis]
15 Chawla U, Chopra D. Structural Advancement in Shoc2‐MAPK Signaling Pathways in the Treatment of Cancer and Other Diseases. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202203791] [Reference Citation Analysis]
16 Maulahela H, Doohan D, Rezkhita YAA, Syam AF, Waskito LA, Savitri CMA, Richardo M, Rahman A, Namara YS, Shatri H, Sanityoso A, Siregar GA, Sudarmo E, Uchida T, Vilaichone R, Yamaoka Y, Miftahussurur M. Helicobacter pylori prevalence in Indonesia: Higher infection risk in Eastern region population. F1000Res 2022;11:1581. [DOI: 10.12688/f1000research.127094.1] [Reference Citation Analysis]
17 Ojima H, Kuraoka S, Okanoue S, Okada H, Gotoh K, Matsushita O, Watanabe A, Yokota K. Effects of Helicobacter pylori and Nitrate-Reducing Bacteria Coculture on Cells. Microorganisms 2022;10. [PMID: 36557748 DOI: 10.3390/microorganisms10122495] [Reference Citation Analysis]
18 Ghafari F, Alizadeh AM, Agah S, Irani S, Mokhtare M. Insulin-like growth factor 1 serum levels in different stages of gastric cancer and their association with Helicobacter pylori status. Peptides 2022;158:170892. [PMID: 36240982 DOI: 10.1016/j.peptides.2022.170892] [Reference Citation Analysis]
19 Li N, Meng G, Yang C, Li H, Liu L, Wu Y, Liu B. Changes in epigenetic information during the occurrence and development of gastric cancer. The International Journal of Biochemistry & Cell Biology 2022;153:106315. [DOI: 10.1016/j.biocel.2022.106315] [Reference Citation Analysis]
20 Freire de Melo F, Marques HS, Rocha Pinheiro SL, Lemos FFB, Silva Luz M, Nayara Teixeira K, Souza CL, Oliveira MV. Influence of Helicobacter pylori oncoprotein CagA in gastric cancer: A critical-reflective analysis. World J Clin Oncol 2022; 13(11): 866-879 [DOI: 10.5306/wjco.v13.i11.866] [Reference Citation Analysis]
21 Zhang Q, Dan J, Meng S, Li Y, Li J. TLR4 inhibited autophagy by modulating PI3K/AKT/mTOR  signaling pathway in GC cell lines.. [DOI: 10.21203/rs.3.rs-2085848/v1] [Reference Citation Analysis]
22 Freire de Melo F, Marques HS, Fellipe Bueno Lemos F, Silva Luz M, Rocha Pinheiro SL, de Carvalho LS, Souza CL, Oliveira MV. Role of nickel-regulated small RNA in modulation of Helicobacter pylori virulence factors. World J Clin Cases 2022; 10(31): 11283-11291 [DOI: 10.12998/wjcc.v10.i31.11283] [Reference Citation Analysis]
23 Gong Y, Luo Y, Chen Z, Sui Y, Zheng Y. Longitudinal analysis of factors related to Helicobacter pylori infection in Chinese adults. Open Medicine 2022;17:1742-1749. [DOI: 10.1515/med-2022-0564] [Reference Citation Analysis]
24 Senchukova MA. Helicobacter Pylori and Gastric Cancer Progression. Curr Microbiol 2022;79:383. [DOI: 10.1007/s00284-022-03089-9] [Reference Citation Analysis]
25 Yun CH, Kao WC, Hsu CY, Chang R, Cheng MF, Hung YM. Nontyphoidal Salmonella Infection Associated with Subsequent Risk of Hematological Malignancies: A Nationwide Population-Based Cohort Study. Int J Environ Res Public Health 2022;19. [PMID: 36232242 DOI: 10.3390/ijerph191912943] [Reference Citation Analysis]
26 Baranovsky AY, Tsvetkova TL. The stomach cancer prognosis map is the basis for the formation of a register of patients with precancerous diseases. jour 2022. [DOI: 10.31146/1682-8658-ecg-205-9-39-45] [Reference Citation Analysis]
27 Wang Q, Guo F, Jin Y, Ma Y. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduct Target Ther 2022;7:336. [PMID: 36167824 DOI: 10.1038/s41392-022-01194-6] [Reference Citation Analysis]
28 Mi C, Zhao Y, Ren L, Zhang D. Inhibition of MDFI attenuates proliferation and glycolysis of Helicobacter pylori ‐infected gastric cancer cells by inhibiting Wnt/β‐catenin pathway. Cell Biology International. [DOI: 10.1002/cbin.11907] [Reference Citation Analysis]
29 Pan D, Sun GJ, Su M, Wang X, Yan QY, Song G, Wang YY, Xu DF, Wang NN, Wang SK. Inverse relations between Helicobacter pylori infection and risk of esophageal precancerous lesions in drinkers and peanut consumption. World J Gastrointest Oncol 2022; 14(9): 1689-1698 [DOI: 10.4251/wjgo.v14.i9.1689] [Reference Citation Analysis]
30 Xu H, Cao C, Ren Y, Weng S, Liu L, Guo C, Wang L, Han X, Ren J, Liu Z. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment. Front Immunol 2022;13:949490. [DOI: 10.3389/fimmu.2022.949490] [Reference Citation Analysis]
31 Ebrahimi Z, Masoodi M, Aslani Z, Naghshi S, Khalighi Sikaroudi M, Shidfar F. Association between dietary antioxidant index and risk of Helicobacter pylori infection among adults: a case-control study. BMC Gastroenterol 2022;22:413. [PMID: 36068529 DOI: 10.1186/s12876-022-02488-3] [Reference Citation Analysis]
32 Hashemi Doulabi MS, Ghaedi K, Ranji N, Khazaei Koohpar Z. rs5745676 of HGF 3’UTR associates with hsa-miR-340-5p binding potential in breast cancer and gastric cancer in Isfahan population. Human Gene 2022;33:201075. [DOI: 10.1016/j.humgen.2022.201075] [Reference Citation Analysis]
33 Wang L, Xiao S, Zheng Y, Gao Z. Interaction Between Vascular Endothelial Growth Factor Gene Polymorphism and Smoking on Gastric Cancer Risk in Chinese Han Population. Pathol Oncol Res 2022;28:1610495. [DOI: 10.3389/pore.2022.1610495] [Reference Citation Analysis]
34 Aziz S, Rasheed F, Akhter TS, Zahra R, König S. Microbial Proteins in Stomach Biopsies Associated with Gastritis, Ulcer, and Gastric Cancer. Molecules 2022;27:5410. [DOI: 10.3390/molecules27175410] [Reference Citation Analysis]
35 Zhang P, Zhang X, Zhu N, Zhuang F, Zhou D, Wang P, Che H. Clinical Efficacy, Survival, and Adverse Reaction Evaluation of Immune Checkpoint Inhibitor in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/6998090] [Reference Citation Analysis]
36 Arismendi Sosa AC, Mariani ML, Vega AE, Penissi AB. Extra virgin olive oil inhibits Helicobacter pylori growth in vitro and the development of mice gastric mucosa lesions in vivo. Front Microbiol 2022;13:961597. [DOI: 10.3389/fmicb.2022.961597] [Reference Citation Analysis]
37 Wu L, Jiang F, Shen X. Helicobacter pylori CagA Protein Regulating the Biological Characteristics of Gastric Cancer through the miR-155-5p/SMAD2/SP1 axis. Pathogens 2022;11:846. [DOI: 10.3390/pathogens11080846] [Reference Citation Analysis]
38 Yalinbaş Kaya B, Tuğrul F. The relationship between colorectal cancer and gastric histopathology: case-control study. J Health Sci Med / JHSM 2022;5:1145-1150. [DOI: 10.32322/jhsm.1118677] [Reference Citation Analysis]
39 Fu YL, Wu YH, Cao DH, Jia ZF, Shen A, Jiang J, Cao XY. Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients. World J Gastrointest Oncol 2022; 14(7): 1295-1306 [DOI: 10.4251/wjgo.v14.i7.1295] [Reference Citation Analysis]
40 Sadjadi A, Akbarpour E, Alimohammadian M, Masoudi S, Ghanbari R, Rajabi Pour Z, Mohmmad Akbari F, Jafari MD, Feiz-Sani A, Hakimi H, Siavooshi F, Massarrat S, Malekzadeh R. A Population-Based Cross-sectional Study on the Prevalence and Associated Risk Factors of Helicobacter pylori Infection in Rafsanjan, a Low Gastric Cancer Area in Southeast Iran. Middle East J Dig Dis 2022;14:287-93. [PMID: 36619268 DOI: 10.34172/mejdd.2022.285] [Reference Citation Analysis]
41 Mărginean CO, Meliț LE, Săsăran MO. Traditional and Modern Diagnostic Approaches in Diagnosing Pediatric Helicobacter pylori Infection. Children 2022;9:994. [DOI: 10.3390/children9070994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Liu L, Ling H, Zhang W, Zhou Y, Li Y, Peng N, Zhao S. Functional Comparison of Clostridium butyricum and Sodium Butyrate Supplementation on Growth, Intestinal Health, and the Anti-inflammatory Response of Broilers. Front Microbiol 2022;13:914212. [PMID: 35722291 DOI: 10.3389/fmicb.2022.914212] [Reference Citation Analysis]
43 Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S. STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response. Pharmacol Res 2022;:106311. [PMID: 35716914 DOI: 10.1016/j.phrs.2022.106311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Guerreiro SFC, Dias AG, Granja PL, Dias JR. Gastroretentive Electrospun Nanofibers Used in Gastric Wall Wound Healing. Materiais 2022 2022. [DOI: 10.3390/materproc2022008048] [Reference Citation Analysis]
45 Sathianarayanan S, V A, Biswas R, B A, Sukumaran S, Venkidasamy B. A new approach against Helicobacter pylori using plants and its constituents: A review study. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 He C, Kong F, Chai X, Zou C, Zhu X, Zhao D, Tan LTH. Effect of Probiotic-Assisted Eradication of cagA+/vacA s1m1 Helicobacter pylori on Intestinal Flora. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/8607671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Bai H, Yang J, Meng S, Liu C. Oral Microbiota-Driven Cell Migration in Carcinogenesis and Metastasis. Front Cell Infect Microbiol 2022;12:864479. [DOI: 10.3389/fcimb.2022.864479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Bao Y, Cheng Y, Liu W, Luo W, Zhou P, Qian D. Bacteria−Based Synergistic Therapy in the Backdrop of Synthetic Biology. Front Oncol 2022;12:845346. [DOI: 10.3389/fonc.2022.845346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Zhang L, Huang M, Li D, Zhang Y, Lan S, Luo Q, Dai Y, Wu Y, Ye J, Chen W, Li R, Hu L. The Single-Nucleotide Polymorphism of miR-27a rs895819 and the Expression of miR-27a in Helicobacter pylori-Related Diseases and the Correlation with the Traditional Chinese Medicine Syndrome. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/3086205] [Reference Citation Analysis]
50 Di J, Chai Y, Yang X, Dong H, Jiang B, Ji F. ELP6 and PLIN5 Mutations Were Probably Prognostic Biomarkers for Patients With Gastric Cancer. Front Med (Lausanne) 2022;9:803617. [PMID: 35223903 DOI: 10.3389/fmed.2022.803617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Cardos AI, Maghiar A, Zaha DC, Pop O, Fritea L, Miere (Groza) F, Cavalu S. Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools. Diagnostics 2022;12:508. [DOI: 10.3390/diagnostics12020508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
52 Liu Z, Hu K, Wang X, Zhang Y, Wang W, Wu Y. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells. Open Medicine 2022;17:266-79. [DOI: 10.1515/med-2021-0406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 张 碧. Significance of Helicobacter pylori and Its Serological Typing in Gastric Cancer. ACM 2022;12:11694-11702. [DOI: 10.12677/acm.2022.12121685] [Reference Citation Analysis]
54 Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
56 Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer: current understanding and mechanistic implications. Clin Transl Oncol 2021. [PMID: 34387847 DOI: 10.1007/s12094-021-02690-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 de Brito BB, Lemos FFB, Carneiro CDM, Viana AS, Barreto NMPV, Assis GAS, Braga BDC, Santos MLC, Silva FAFD, Marques HS, Silva NOE, de Melo FF. Immune response to Helicobacter pylori infection and gastric cancer development. World J Meta-Anal 2021; 9(3): 257-276 [DOI: 10.13105/wjma.v9.i3.257] [Reference Citation Analysis]
58 Muhammad Rashad JMB, Department of biology, Faculty of Science, University of Kufa, Iraq, Jaloob Aljanaby AAJ, Department of biology, Faculty of Science, University of Kufa, Iraq. ROLE OF INTERLEUKIN-2, INTERLEUKIN-4 AND CLUSTER OF DIFFERENTIATION-22 AS AN IMMUNE MARKERS IN INDIVIDUALS INFECTED WITH Helicobacter pylori. JEBAS 2021;9:388-393. [DOI: 10.18006/2021.9(3).388.393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
59 Deptuła P, Suprewicz Ł, Daniluk T, Namiot A, Chmielewska SJ, Daniluk U, Lebensztejn D, Bucki R. Nanomechanical Hallmarks of Helicobacter pylori Infection in Pediatric Patients. Int J Mol Sci 2021;22:5624. [PMID: 34070700 DOI: 10.3390/ijms22115624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Krzyżek P, Grande R, Migdał P, Paluch E, Gościniak G. Biofilm Formation as a Complex Result of Virulence and Adaptive Responses of Helicobacter pylori. Pathogens 2020;9:E1062. [PMID: 33353223 DOI: 10.3390/pathogens9121062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]